reasons, the Committee did not consider the abuse liability of MBDB would constitute a significant risk to public health, thereby warranting its placement under international control. Scheduling of MBDB was therefore not recommended. Australia MBDB is considered a Schedule 9 Prohibited substance in Australia under the Poisons Standard (October 2015). A Schedule 9 substance is a substance which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities. Russia MBDB is included into Schedule 1 of the Controlled Substances Act. Sweden Sveriges riksdags health ministry Statens folkhälsoinstitut classified MBDB as "health hazard" under the act Lagen om förbud mot vissa hälsofarliga varor (translated Act on the Prohibition of Certain Goods Dangerous to Health) as of Feb 25, 1999, in their regulation SFS 1999:58 listed as "2-metylamino-1-(3,4-metylendioxifenyl)-butan (MBDB)", making it illegal to sell or possess. See also Ethylbenzodioxolylbutanamine (EBDB; Ethyl-J) Methylbenzodioxolylpentanamine (MBDP; Methyl-K) UWA-101 References External links PiHKAL entry METHYL-J (MBDB) entry in PiHKAL • info Erowid MBDB vault Substituted amphetamines Entactogens and empathogens Benzodioxoles Designer drugs Serotonin-norepinephrine-dopamine releasing agents